Differential Inhibition by Nimesulide of the Early and Late Phases of Intravenous- and Intracerebroventricular-LPS-Induced Fever in Guinea Pigs
The DOI matches its Crossref record; 54 of the 54 references it cites were found in a registry or an index.
Abstract
Objectives: The findings that inducible cyclooxygenase (COX)-2, but not constitutive COX-1, is upregulated in the brain of conscious rats ∼1.5 h after intraperitoneal pyrogen administration, that the systemic administration of COX-2 inhibitors abolishes fever, and that COX-2-deficient mice do not develop fever in response to intraperitoneal lipopolysaccharide (LPS) have strongly implicated COX-2 in the mediation of the febrile response. However, the biosynthesis of COX-2 is significantly slower than the onset of the fever produced by intravenously injected LPS. It consequently seems improbable that inducible COX-2 could play a role in the initiation of this febrile response, but a role for COX-1 has not yet been categorically ruled out; or, alternatively, a constitutive isoform of COX-2 could have such a role. We have studied, therefore, the effects of the non-selective COX inhibitor indomethacin, the COX-1-selective inhibitor SC-560, and the COX-2-selective inhibitor nimesulide on the characteristically biphasic fever induced by intravenous LPS in conscious guinea pigs; it has an onset latency of ∼10 min. Methods: We injected the inhibitors 30 min before LPS, in various combinations of doses and routes; their respective vehicles were the control solutions. Core temperatures (T c) were monitored continuously, and plasma and brain PGE 2 levels were measured before and at 2-hour intervals after LPS administration. Results: Intraperitoneal indomethacin at 10 mg kg–1 attenuated both phases of intravenous LPS (2 µg kg–1) fever, but the first more so than the second; at 50 mg kg–1, it inhibited the febrile response completely. Intraperitoneal SC-560 (5 mg kg–1) did not affect the febrile response to intravenous LPS (2 µg kg–1). Intraperitoneal nimesulide (0.3, 1.0, and 3.0 mg kg–1) dose dependently attenuated intravenous LPS (0.1 and 2 µg kg–1) fever; the second phase of the biphasic T c rise was affected significantly more than the first. Intraperitoneal nimesulide also prevented the associated rises in plasma and brain PGE 2 levels. Intracerebroventricular LPS (150 ng kg–1) evoked a monophasic fever with a long onset latency (∼30 min); it was accompanied by a rise in brain PGE 2 only, implying that the febrigenic PGE 2 was generated directly in the brain. This response, however, was completely abolished by intraperitoneal nimesulide (3 mg kg–1), indicating that nimesulide crosses the blood-brain barrier. Intracerebroventricular nimesulide at 0.3 mg kg–1 prevented the rise in plasma PGE 2 after intravenous LPS (2 µg kg–1) and again attenuated the second febrile peak significantly more than the first. Conclusions: COX-1 is not involved in intravenous LPS fever production, and COX-2 appears to play a greater role in the late than in the early phase of intravenous LPS fever in guinea pigs. The involvement of a constitutive COX-2 is inferred in the early phase.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“It is therefore not surprising that SC560, a selective COX-1 inhibitor, does not exhibit antipyretic actions [125].”
From Paracetamol (acetaminophen): A familiar drug with an unexplained mechanism of action (2021) · cites this paper as [125]
In the citing paper
“Blockade of brain PGE 2 synthesis by NSAIDs has been associated with the antipyretic action of these drugs, which has been suggested to be due to inhibition of inducible COX-2 produced by hypothalamic vascular endothelial cells [124,125].”
From Paracetamol (acetaminophen): A familiar drug with an unexplained mechanism of action (2021) · cites this paper as [125]
Citations
Cites
Yamagata, K., Andreasson, K. I., Kaufmann, W. E., Barnes, C. A., & Worley, P. F. (1993) · Neuron · doi:10.1016/0896-6273(93)90192-t · Cited by 1,226
Fever: Role of Pyrogens and Cryogens
Kluger, M. J. (1991) · Physiological Reviews · doi:10.1152/physrev.1991.71.1.93 · Cited by 1,215
Herschman, H. R. (1996) · Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism · doi:10.1016/0005-2760(95)00194-8 · Cited by 1,197
Pharmacological analysis of cyclooxygenase-1 in inflammation
Smith, C. J., Zhang, Y., Koboldt, C. M., Muhammad, J., Zweifel, B. S., Shaffer, A., Talley, J. J., Masferrer, J. L., Seibert, K., & Isakson, P. C. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.22.13313 · Cited by 807
Tanioka, T., Nakatani, Y., Semmyo, N., Murakami, M., & Kudo, I. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m003504200 · Cited by 708
Cyclooxygenase-2: Molecular Biology, Pharmacology, and Neurobiology
O'Banion, M. K. (1999) · Critical Reviews in Neurobiology · doi:10.1615/critrevneurobiol.v13.i1.30 · Cited by 404
Yamagata, K., Matsumura, K., Inoue, W., Shiraki, T., Suzuki, K., Yasuda, S., Sugiura, H., Cao, C., Watanabe, Y., & Kobayashi, S. (2001) · The Journal of Neuroscience · doi:10.1523/jneurosci.21-08-02669.2001 · Cited by 371
Mechanism of Action of Acetaminophen: Is There a Cyclooxygenase 3?
Botting, R. M. (2000) · Clinical Infectious Diseases · doi:10.1086/317520 · Cited by 350
Pathway across the blood–brain barrier
Ek, M., Engblom, D., Saha, S., Blomqvist, A., Jakobsson, P.-J., & Ericsson-Dahlstrand, A. (2001) · Nature · doi:10.1038/35068632 · Cited by 348
Murakami, M., Kambe, T., Shimbara, S., & Kudo, I. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.5.3103 · Cited by 348
Cited by
Chandrasekharan, N. V., Dai, H., Roos, K. L. T., Evanson, N. K., Tomsik, J., Elton, T. S., & Simmons, D. L. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.162468699 · Cited by 1,989
Maulik, P. K., & Darmstadt, G. L. (2007) · Pediatrics · doi:10.1542/peds.2007-0043b · Cited by 296
Konsman, J. P., Vigues, S., Mackerlova, L., Bristow, A., & Blomqvist, A. (2004) · Journal of Comparative Neurology · doi:10.1002/cne.20052 · Cited by 257
“…cells expressing IL-1R1s plays an important role after LPS administration is supported by the finding that the IL-1 receptor antagonist inhibits LPS-induced fever (Luheshi et al., 1996), a COX-2 dependent response (Cao et al., 1997; Steiner et al., 2001; Roth et al., 2002; Zhang et al., 2003).”
BackgroundProstaglandin E2 as a mediator of fever: synthesis and catabolism
Ivanov, A. (2004) · Frontiers in Bioscience · doi:10.2741/1383 · Cited by 242
“Differential regulation at three phases of lipopolysaccharide fever Studies with pharmacological inhibition of PG synthesis (10, 13, 14, 66) and experiments in PGE receptor knockout mice (5) strongly suggest that PGE2 is involved in all three febrile phases.”
BackgroundInfluentialParacetamol (acetaminophen): A familiar drug with an unexplained mechanism of action
Ayoub, S. S. (2021) · Temperature · doi:10.1080/23328940.2021.1886392 · Cited by 223
“Blockade of brain PGE2 synthesis by NSAIDs has been associated with the antipyretic action of these drugs, which has been suggested to be due to inhibition of inducible COX-2 produced by hypothalamic vascular endothelial cells [124,125].”
Background
Metadata
- Authors
- Steiner, A. A., Li, S., Llanos-Q., J., & Blatteis, C. M.
- Affiliations
- University of Tennessee Health Science Center (US)
- Venue
- Neuroimmunomodulation
- Publisher
- S. Karger AG
- Published
- 2001
- Volume
- 9
- Issue
- 5
- Pages
- 263-275
- ISSN
- 1021-7401 (ISSN-L)
- 1423-0216
- OpenAlex
- W1964949469
- Cited by
- 50
- References
- 54
- Citations by year
- 2024: 1 · 2023: 1 · 2021: 2 · 2018: 3 · 2017: 2 · 2015: 1 · 2014: 2
- FWCI
- 4.24
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.karger.com/Services/SiteLicenses (vor)
- www.karger.com/Services/SiteLicenses (tdm)
- Locations
- NeuroImmunoModulation (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institute of Neurological Disorders and Stroke (NS/AI38594)
- Topics
- Health Sciences › Medicine › Critical Care and Intensive Care Medicine › Thermal Regulation in Medicine
- Health Sciences › Medicine › Pharmacology (medical) › Inflammatory mediators and NSAID effects
- Health Sciences › Medicine › Physiology (medical) › Pain Mechanisms and Treatments
- Keywords
- nimesulide, lipopolysaccharide-induced fever, biphasic fever, cyclooxygenase-2, cyclooxygenase-1, indomethacin, SC-560, febrile response, prostaglandin E2, guinea pig
- MeSH terms
- Animals, Anti-Inflammatory Agents, Non-Steroidal, Blood-Brain Barrier, Brain, Dose-Response Relationship, Drug, Fever, Guinea Pigs, Indomethacin, Injections, Intraperitoneal, Injections, Intravenous, Injections, Intraventricular, Isoenzymes, Lipopolysaccharides, Male, Prostaglandin-Endoperoxide Synthases, Pyrazoles, Sulfonamides, Dinoprostone, Cyclooxygenase Inhibitors, Cyclooxygenase 1, Cyclooxygenase 2, Cyclooxygenase 2 Inhibitors
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Differential Inhibition by Nimesulide of the Early and Late Phases of Intravenous- and Intracerebroventricular-LPS-Induced Fever in Guinea Pigs. https://app.cochat.ai/papers/10.1159/000054289
- The paper
- Steiner, A. A., Li, S., Llanos-Q., J., & Blatteis, C. M. (2001). Differential Inhibition by Nimesulide of the Early and Late Phases of Intravenous- and Intracerebroventricular-LPS-Induced Fever in Guinea Pigs. Neuroimmunomodulation. https://doi.org/10.1159/000054289
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.